Join Growin Stock Community!

生泰1777.TW Overview

TW StockBiotech. & Medical
(No presentation for 1777)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

生泰（1777）Overall Performance

生泰（1777）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

生泰（1777） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

生泰（1777）Key Information

生泰（1777）Profile

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, dipeptidyl peptidase 4 inhibitor/antidiabetic, antihyertensive, a- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, hvponatremia, antiglaucoma agent, pharmaceutic aid / lubricant, sedative, and analgesic. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

生泰（1777）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
12.50
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.64%
Net Margin
20.12%
Revenue Growth (YoY)
3.39%
Profit Growth (YoY)
-7.51%
3-Year Revenue Growth
9.19%
3-Year Profit Growth
9.92%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
12.50
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
34.64%
Net Margin
20.12%
Revenue Growth (YoY)
3.39%
Profit Growth (YoY)
-7.51%
3-Year Revenue Growth
9.19%
3-Year Profit Growth
9.92%
default symbol

1777

生泰

72.50D

0.41%

(0.00)

  • When is 1777's latest earnings report released?

    The most recent financial report for 生泰 (1777) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1777's short-term business performance and financial health. For the latest updates on 1777's earnings releases, visit this page regularly.

  • Where does 1777 fall in the P/E River chart?

    According to historical valuation range analysis, 生泰 (1777)'s current price-to-earnings (P/E) ratio is 9.86, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 1777?

    According to the latest financial report, 生泰 (1777) reported an Operating Profit of 95.64M with an Operating Margin of 29.61% this period, representing a growth of 2.36% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 1777's revenue growth?

    In the latest financial report, 生泰 (1777) announced revenue of 322.95M, with a Year-Over-Year growth rate of 2.76%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 1777 have?

    At the end of the period, 生泰 (1777) held Total Cash and Cash Equivalents of 1.05B, accounting for 0.35 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 1777 go with three margins increasing?

    In the latest report, 生泰 (1777) achieved the “three margins increasing” benchmark, with a gross margin of 40.78%%, operating margin of 29.61%%, and net margin of 28.45%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1777's profit trajectory and future growth potential.

  • Is 1777's EPS continuing to grow?

    According to the past four quarterly reports, 生泰 (1777)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.06. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 1777?

    生泰 (1777)'s Free Cash Flow (FCF) for the period is -2.66M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 156.26% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.